Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Ceftizoxime

Copy Product Info
🥰Excellent
Catalog No. T4501Cas No. 68401-81-0
Alias Epocelin

Ceftizoxime (Epocelin) is a cephalosporin-based, potent antibacterial agent which can be administered intravenously or by suppository. It is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms.

Ceftizoxime

Ceftizoxime

Copy Product Info
🥰Excellent
Purity: 99.91%
Catalog No. T4501Alias EpocelinCas No. 68401-81-0
Ceftizoxime (Epocelin) is a cephalosporin-based, potent antibacterial agent which can be administered intravenously or by suppository. It is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$33In StockIn Stock
50 mg$44In StockIn Stock
100 mg$70In StockIn Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.91%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Ceftizoxime AI Summary
Ceftizoxime demonstrates a range of bioactivities and pharmacokinetic properties. It acts as a potent antimicrobial agent with in vitro minimum inhibitory concentrations (MIC) values as low as 0.025 µg/mL against Escherichia coli, Klebsiella pneumonia, and Proteus mirabilis. It also shows activity against other bacteria like Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa, and Serratia marcescens with MIC values from 6.25 to 50.0 µg/mL. Additionally, it exhibits activity against various strains of Staphylococcus, including oxacillin-resistant and methicillin-resistant strains, with MIC values ranging from 0.12 to 800.0 µg/mL. Pharmacokinetically, Ceftizoxime has a plasma half-life of approximately 0.25 hours in rats, 0.7333 hours in monkeys, and 1.6 hours in humans after intravenous administration. It shows a total body clearance (CL) of 2.1 mL/min/kg and a renal clearance (CL_renal) of 1.68 mL/min/kg in humans. The compound has good pharmacokinetic properties with a half-life ranging from 0.22 to 0.23 hours, and a high fAUC/MIC ratio of 1000.0, indicating its potential as an effective antimicrobial agent. Ceftizoxime also shows significant liver enzyme activity, increasing levels of alkaline phosphatase, SGOT, SGPT, and LDH, although it has no observed bioactivities related to drug-induced liver injury according to the Drug Induced Liver Injury Prediction System (DILIps). The compound is a substrate for the human MRP4 transporter, with a Km value of 18000.0 nM, and exhibits inhibitory activity against the human HDAC6 enzyme, indicating potential as an HDAC6 inhibitor. It also exhibits bioactivity as a binding agent to multiple receptors and shows various activities including agonist and antagonist actions with high AC50 values above 17000.0 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Ceftizoxime (Epocelin) is a cephalosporin-based, potent antibacterial agent which can be administered intravenously or by suppository. It is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms.
SynonymsEpocelin
Chemical Properties
Molecular Weight383.40
FormulaC13H13N5O5S2
Cas No.68401-81-0
SmilesO=C1N2[C@@]([C@@H]1NC(/C(=N\OC)/C3=CSC(N)=N3)=O)(SCC=C2C(O)=O)[H]
Relative Density.1.89 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 25.00 mg/mL (65.21 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.00 mg/mL (5.22 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.6082 mL13.0412 mL26.0824 mL130.4121 mL
5 mM0.5216 mL2.6082 mL5.2165 mL26.0824 mL
10 mM0.2608 mL1.3041 mL2.6082 mL13.0412 mL
20 mM0.1304 mL0.6521 mL1.3041 mL6.5206 mL
50 mM0.0522 mL0.2608 mL0.5216 mL2.6082 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Ceftizoxime | purchase Ceftizoxime | Ceftizoxime cost | order Ceftizoxime | Ceftizoxime chemical structure | Ceftizoxime formula | Ceftizoxime molecular weight